CeriBell (NASDAQ:CBLL) outlined its recent progress and 2026 priorities at a JPMorgan MedTech event, emphasizing continued ...

Roughly 25 percent of dementia patients were prescribed at least one ‘potentially inappropriate’ drug between 2013 and 2021 ...

Researchers are sounding the alarm on dangerous stimulant medications commonly prescribed to dementia patients in the U.S.

CeriBell Inc. CBLL recently announced that the FDA has granted Breakthrough Device Designation for its Large Vessel Occlusion ...

From prayer times to family vigils, everyday realities can alter how delirium presents — and how clinicians should respond.

Ceribell announced today that the FDA granted breakthrough device designation for its large vessel occlusion (LVO) stroke ...

Clearance would position the Ceribell System as the first and only point-of-care electroencephalography (EEG) technology to ...

CeriBell (CBLL) announced that the U.S. Food and Drug Administration has granted Breakthrough Device Designation for its Large Vessel Occlusion ...

Background: Delirium in intensive care unit (ICU) patients poses a significant challenge, affecting patient outcomes and health care efficiency. Developing an accurate, real-time prediction model for ...

After several years away, The Claypool Lennon Delirium is coming back in 2026. Guitarist/vocalist Sean Ono Lennon revealed in an interview with CBS Sunday Morning that his project with Primus bassist ...